Suchergebnisse - "Borzio, Mauro"

PubPharm (65)

1

Multidisciplinary treatment of hepatocellular carcinoma in 2023 : Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) - Part II - Non-surgical treatments

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2024

von Cabibbo, G. | Daniele, B. | Borzio, M. | +22

2

Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023 : Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) - Part I - Surgical treatments

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2024

von Cabibbo, G. | Daniele, B. | Borzio, M. | +22

3

Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib : A Counterfactual Event-Based Mediation Analysis

enthalten in: Cancers | 2023

von Sacco, R. | Ramai, D. | Tortora, R. | +30

4

Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma

enthalten in: Journal of clinical medicine | 2022

von Guarino, M. | Cossiga, V. | Capasso, M. | +65

5

Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice

enthalten in: Cancers | 2019

von Giannini, E. | Aglitti, A. | Borzio, M. | +15

6

enthalten in: Hepatology (Baltimore, Md.) | 2019

von Vitale, A. | Farinati, F. | Borzio, M. | +2

CommentOn: Hepatology. 2018 Oct;68(4):1232-1244. - PMID 30048016

7

Status of, and strategies for improving, adherence to HCC screening and surveillance

enthalten in: Journal of hepatocellular carcinoma | 2019

von Francica, G. | Borzio, M.

8

Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions : A Multicenter Cohort Study

enthalten in: Hepatology (Baltimore, Md.) | 2018

von Vitale, A. | Farinati, F. | Noaro, G. | +38

CommentIn: Hepatology. 2019 Jan;69(1):464-465. - PMID 30353930

9

External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma : A multicenter cohort study

enthalten in: Hepatology (Baltimore, Md.) | 2018

von Borzio, M. | Dionigi, E. | Rossini, A. | +13

CommentIn: Hepatology. 2018 Jun;67(6):2076-2078. - PMID 29266394

10

Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions : A Multicenter Cohort Study

enthalten in: Hepatology | 2018

von Vitale, A. | Farinati, F. | Noaro, G. | +37

1
2
3
4
5
6
7
Nächster »
[7]